Lorcaserin Extended-Release Tablets and Rotigotine transdermal
Determining the interaction of Lorcaserin Extended-Release Tablets and Rotigotine transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: rotigotine
Brand name: Neupro
Synonyms: Rotigotine (transdermal), Rotigotine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Rowasa
- Lorcaserin Extended-Release Tablets-Rowasa rectal
- Lorcaserin Extended-Release Tablets-Roweepra
- Lorcaserin Extended-Release Tablets-Roweepra XR
- Lorcaserin Extended-Release Tablets-Roxal-Estradiol Derm 100 Transdermal
- Lorcaserin Extended-Release Tablets-Roxanol
- Rotigotine transdermal-Lorcaserin Hydrochloride
- Rotigotine transdermal-Lorcaserin Tablets
- Rotigotine transdermal-Lorcet
- Rotigotine transdermal-Lorcet Plus
- Rotigotine transdermal-Lorcet Tablets
- Rotigotine transdermal-Lorlatinib